Study of Some Genetic Variants for Cancer in Women with Breast Cancer in the East Azarbaijan Region by MLPA Method
Mahdiyeh Pashaei1, Jamal EivaziZiaei2, Alireza Nikanfar3, Babak Emamalizadeh4 and Seyyed Mojtaba Mohaddes Ardebili5
1Hematology and Medical Oncology, Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Department of Biochemistry and Clinical Laboratories, Division of Medical Genetics,Tabriz University of Medical Sciences, Tabriz, Iran.
2Hematology and Medical Oncology, Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Iran.
3Tabriz University Hematology and Oncology Research Center, Shahid Ghazi Hematology and Oncology Ward.
4Department of Medical Genetics, Tabriz University of Medical Sciences, Tabriz, Medical Genetics.
5Department of Biochemistry and Clinical Laboratories, Division of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Corresponding Author E-mail: mojtabamohaddesardebili197@gmail.com
DOI : http://dx.doi.org/10.13005/bbra/2675
ABSTRACT: Breast cancer is one of the main factors in the mortality of Iranian women. A large rearrangement genome is observed in most genes, especially in BRCA1 / BRCA2 genes lacking small mutations in breast cancer. Therefore, methods are needed to detect one or more exon deletions or their duplication. Therefore, the aim of this study was to determine the change in the number of copies of ATM, BRCA1, CHEK2, PTEN, and P53 genes in women with breast cancer in the East Azarbaijan region by MLPA method. This research is a descriptive study that was conducted randomly among 150 Azeri women with breast cancer who were referred to Tabriz Nour Najat Hospital; sixteen healthy people were selected as control samples. Deletion and duplication of ATM, BRCA1, P53, CHEK2 and PTEN genes were investigated using the MLPA method. The results showed that there was no pathogenicity mutation in these five genes. Therefore, it can be said that a large rearrangement genome in the East Azarbaijan province is very unlikely to lead to breast cancer in the area.
KEYWORDS: ATM; BRCA1; Breast Cancer; CHEK2; MLPA; P53 PTEN;
Download this article as:Copy the following to cite this article: Pashaei M, EivaziZiaei J, Nikanfar A, Emamalizadeh B, Ardebili S. M. M. Study of Some Genetic Variants for Cancer in Women with Breast Cancer in the East Azarbaijan Region by MLPA Method. Biosci Biotech Res Asia 2018;15(3). |
Copy the following to cite this URL: Pashaei M, EivaziZiaei J, Nikanfar A, Emamalizadeh B, Ardebili S. M. M. Study of Some Genetic Variants for Cancer in Women with Breast Cancer in the East Azarbaijan Region by MLPA Method. Biosci Biotech Res Asia 2018;15(3). Available from: https://www.biotech-asia.org/?p=31204 |